April 24, 2018

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) And Partner Present Data In Line With Epidiolex®

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) has moved ahead to make the pronouncement that it will be undertaking data presentation from the  pivotal Phase 3 trials of […]
March 26, 2018

Rite Aid Corporation (NYSE:RAD) And Others Partner To Unveil A Prescription-Drug Safety Program

The stock of Rite Aid Corporation (NYSE:RAD) closed at $1.49 losing 3.25% in yesterday’s trading session. Josh Shapiro, the Pennsylvania Attorney General is at the moment […]
February 26, 2018

Uzbekistan Announces Plan To Support Developers As Well As Legalize Bitcoin

It is expected that any time soon Uzbekistan might be legalizing bitcoin. A person familiar with the most recent development has outlined that the presidential decree […]
December 19, 2017

Amgen Biotech and LabCentral Recommends To Companies For The Amgen Golden Ticket Win

Amgen and LabCentral have nominated two early-stage companies; Kernal Biologics Inc. and QurAlis as the winners of the Amgen Golden Ticket at LabCentral. The winners were […]
December 19, 2017

Gilead Sciences, Inc (NASDAQ:GILD) to Promote John Martin To Become The New Chairman Of The Board Of Directors

The stock of Gilead Sciences, Inc (NASDAQ:GILD) closed at $75.57 gaining 1.65% in yesterday’s trading session. The Executive Chairman of Gilead, John Martin, will in a […]
December 19, 2017

Seed Mena And Jaguar Health Inc (NASDAQ:JAGX) Partner To Carry Out Tests On Equilevia™

The stock Jaguar Health Inc (NASDAQ:JAGX) closed at $0.131gaining 0.77% in yesterday’s trading session. Seed Mena Businessmen Services is making its entry into a collaboration agreement with […]
December 19, 2017

Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) Announces That Ampion Met Its Primary Endpoint

The stock of Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) closed at $2.18 losing 4.80% in yesterday’s trading session. The 50% jump in the shares of Ampio witnessed on […]
December 19, 2017

ImmunoCellular Therapeutics Ltd (NYSEAMERICAN:IMUC) Makes A Move That Inspires Hope Among Cancer Patients

The stock of ImmunoCellular Therapeutics Ltd (NYSEAMERICAN:IMUC) closed at $0.328 losing 18.61% in yesterday’s trading session. It is great news for most of the cancer patients […]